44 research outputs found
Lactic acid fermentation as a tool to enhance the antioxidant properties of Myrtus communis berries
Background: Myrtle (Myrtus communis L.) is a medicinal and aromatic plant belonging to Myrtaceae family, which
is largely diffused in the Mediterranean areas and mainly cultivated in Tunisia and Italy. To the best of our knowledge, no
studies have already considered the use of the lactic acid fermentation to enhance the functional features of M.
communis. This study aimed at using a selected lactic acid bacterium for increasing the antioxidant features of myrtle
berries, with the perspective of producing a functional ingredient, dietary supplement or pharmaceutical preparation.
The antioxidant activity was preliminarily evaluated through in vitro assays, further confirmed through ex vivo analysis on
murine fibroblasts, and the profile of phenol compounds was characterized.
Results: Myrtle berries homogenate, containing yeast extract (0.4%, wt/vol), was fermented with Lactobacillus plantarum
C2, previously selected from plant matrix. Chemically acidified homogenate, without bacterial inoculum and incubated
under the same conditions, was used as the control. Compared to the control, fermented myrtle homogenate exhibited
a marked antioxidant activity in vitro. The radical scavenging activity towards DPPH increased by 30%, and the
inhibition of linoleic acid peroxidation was twice. The increased antioxidant activity was confirmed using Balb 3 T3
mouse fibroblasts, after inducing oxidative stress, and determining cell viability and radical scavenging activity
through MTT and DCFH-DA assays, respectively. The lactic acid fermentation allowed increased concentrations of total
phenols, flavonoids and anthocyanins, which were 5–10 times higher than those found for the non-fermented and
chemically acidified control. As shown by HPLC analysis, the main increases were found for gallic and ellagic acids, and
flavonols (myricetin and quercetin). The release of these antioxidant compounds would be strictly related to the
esterase activities of L. plantarum.
Conclusions: The lactic acid fermentation of myrtle berries is a suitable tool for novel applications as functional
food dietary supplements or pharmaceutical preparations
Expression and function of human hemokinin-1 in human and guinea pig airways
<p>Abstract</p> <p>Background</p> <p>Human hemokinin-1 (hHK-1) and endokinins are peptides of the tachykinin family encoded by the <it>TAC4 </it>gene. <it>TAC4 </it>and hHK-1 expression as well as effects of hHK-1 in the lung and airways remain however unknown and were explored in this study.</p> <p>Methods</p> <p>RT-PCR analysis was performed on human bronchi to assess expression of tachykinin and tachykinin receptors genes. Enzyme immunoassay was used to quantify hHK-1, and effects of hHK-1 and endokinins on contraction of human and guinea pig airways were then evaluated, as well as the role of hHK-1 on cytokines production by human lung parenchyma or bronchi explants and by lung macrophages.</p> <p>Results</p> <p>In human bronchi, expression of the genes that encode for hHK-1, tachykinin NK<sub>1</sub>-and NK<sub>2</sub>-receptors was demonstrated. hHK-1 protein was found in supernatants from explants of human bronchi, lung parenchyma and lung macrophages. Exogenous hHK-1 caused a contractile response in human bronchi mainly through the activation of NK<sub>2</sub>-receptors, which blockade unmasked a NK<sub>1</sub>-receptor involvement, subject to a rapid desensitization. In the guinea pig trachea, hHK-1 caused a concentration-dependant contraction mainly mediated through the activation of NK<sub>1</sub>-receptors. Endokinin A/B exerted similar effects to hHK-1 on both human bronchi and guinea pig trachea, whereas endokinins C and D were inactive. hHK-1 had no impact on the production of cytokines by explants of human bronchi or lung parenchyma, or by human lung macrophages.</p> <p>Conclusions</p> <p>We demonstrate endogenous expression of <it>TAC4 </it>in human bronchi, the encoded peptide hHK-1 being expressed and involved in contraction of human and guinea pig airways.</p
Two patients with occupational asthma who returned to work with dust respirators
OBJECTIVES—To assess the efficacy of dust respirators in preventing asthma attacks in patients with occupational asthma (asthma induced by buckwheat flour or wheat flour).
METHODS—The effect of the work environment was examined in two patients with occupational asthma with and without the use of a commercially available mask or a dust respirator. Pulmonary function tests were performed immediately before and after work and at 1 hourly intervals for 14 hours after returning to the hospital.
RESULTS—In patient 1, environmental exposure resulted in no symptoms during and immediately after work, but coughing, wheezing, and dyspnoea developed after 6 hours. Peak expiratory flow rate (PEFR) decreased by 44% 7 hours after leaving the work environment, showing only a positive late asthmatic reaction (LAR). In patient 2, environmental exposure resulted in coughing and wheezing 10 minutes after initiation during bread making, and PEFR decreased by 39%. After 7 hours, PEFR decreased by 34%. The environmental provocation tests in both patients were repeated after wearing a commercial respirator. This resulted in a complete suppression of LAR in patient 1 and of immediate asthmatic reaction (IAR) and LAR in patient 2.
CONCLUSIONS—Two patients with asthma induced by buckwheat flour or wheat flour in whom asthmatic attacks could be prevented with a dust respirator are reported. Dust respirators are effective in preventing asthma attacks induced by buckwheat flour and wheat flour.


Keywords: asthma: buckwheat flour: wheat flour; environmental provocation tes